The gram negative bacterium Stenotrophomonas is rapidly evolving as a nosocomial pathogen in immuno-compromised patients. Treatment of S. maltophilia infections is problematic because of their increasing resistance to multiple antibiotics. This article aims to review the multi-disciplinary role of Stenotrophomonas in our environment with special focus on their metabolic and genetic potential in relation to bioremediation and phytoremediation. Current and emerging treatments and diagnosis for patients infected with S. maltophilia are discussed besides their capability of production of novel bioactive compounds. The plant growth promoting characteristics of this bacterium has been considered with special reference to secondary metabolite production. Nano-particle synthesis by Stenotrophomonas has also been reviewed in addition to their applications as effective biocontrol agents in plant and animal pathogenesis.
Stenotrophomonas maltophiliaPM102 (NCBI GenBank Acc. no. JQ797560) is capable of growth on trichloroethylene as the sole carbon source. In this paper, we report the purification and characterisation of oxygenase present in the PM102 isolate. Enzyme activity was found to be induced 10.3-fold in presence of 0.7 mM copper with a further increment to 14.96-fold in presence of 0.05 mM NADH. Optimum temperature for oxygenase activity was recorded at. The reported enzyme was found to have enhanced activity at pH 5 and pH 8, indicating presence of two isoforms. Maximum activity was seen on incubation with benzene compared to other substrates like TCE, chloroform, toluene, hexane, and petroleum benzene.andfor benzene were 3.8 mM and 340 U/mg/min and those for TCE were 2.1 mM and 170 U/mg/min. The crude enzyme was partially purified by ammonium sulphate precipitation followed by dialysis. Zymogram analysis revealed two isoforms in the 70% purified enzyme fraction. The activity stain was more prominent when the native gel was incubated in benzene as substrate in comparison to TCE. Crude enzyme and purified enzyme fractions were assayed for TCE degradation by the Fujiwara test. TCE biotransformation products were analysed by FT-IR spectroscopy.
A novel bacterial isolate capable of growth on trichloroethylene as the sole carbon source was identified as Stenotrophomonas maltophilia PM102 by 16S rDNA sequencing (GenBank Acc.no. JQ797560). Serum was obtained from a rabbit immunized with the total protein extracted from the PM102 isolate grown in 0.2% TCE with 0.2% peptone. Antibodies to the common antigens were removed by preadsorbing the serum antibody on total protein extracted from the PM102 strain grown in 0.2% peptone. Western blot with the preadsorbed antibody reacted to a single band in TCE and TCE with peptone lane. No reaction was seen in peptone lane. This preadsorbed antibody specific for TCE inducible antigens was immobilised on epoxy activated sepharose 6B and total protein from PM102 cells grown in minimal medium with TCE as the sole carbon source was purified through the column. The bound protein fraction was eluted and resolved through 12% SDS PAGE. Four prominent bands observed in the protein profile were analysed by matrix-assisted laser desorption/ionization time of flight-mass spectrometry (MS) and tandem mass spectrometry (MS/MS) after in gel digestion with 25 ng/μl trypsin. A number of mono/di-oxygenases that cometabolise TCE in presence of some other primary carbon source are present in literature but this is the first attempt in identification of TCE induced proteins linked to metabolic activity with oxidoreductase like function, from a bacterial isolate that utilises TCE as the sole carbon source.